Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + cob(I)alamin
triphosphate + coenzyme B12
-
-
-
?
ATP + hydroxycobalamin
adenosylcobalamin + phosphate + diphosphate
37°C, pH 8, 0.5 mM ATP, 0.05 mM hydroxycobalamin, in presence of 1 mM titanium(III)citrate
measured by decrease in absorbance at 388 nm
-
?
cob(II)alamin
cob(I)alamin
G97, T161, and H183 possible role in stabilizing four-coordinate, cob(II)alamin C-terminal His-tagged enzyme binds cob(II)alamin base-off while N-terminal His-tagged enzyme binds it base-on (impaired base-off transition), only mutants S68F, K78Q, K78R, R186W, and R190C also bind cob(II)alamin base-off
-
-
?
ATP + cob(I)alamin
triphosphate + adenosylcob(III)alamin
ATP + cob(I)alamin
triphosphate + adenosylcobalamin
cob(I)alamin + ATP
adenosylcobalamin + triphosphate
CTP + cob(I)alamin
triphosphate + cytosylcobalamin
-
polymorphic variants 239K and 239M, 9% activity compared to ATP with enzyme variant 239K, 6% activity compared to ATP with enzyme variant 239M
-
-
?
GTP + cob(I)alamin
triphosphate + guanosylcobalamin
-
polymorphic variants 239K and 239M, 16% activity compared to ATP with enzyme variant 239K, 14% activity compared to ATP with enzyme variant 239M
-
-
?
UTP + cob(I)alamin
triphosphate + uridylcobalamin
-
polymorphic variants 239K and 239M, 8% activity compared to ATP with enzyme variant 239K, 6% activity compared to ATP with enzyme variant 239M
-
-
?
additional information
?
-
ATP + cob(I)alamin
triphosphate + adenosylcob(III)alamin
-
-
adenosyltransferase enzymes lower the thermodynamic barrier of the Co2+ toCo+ reduction needed for the formation of the unique organometalic Co-C bond of adenosylcobalamin
-
?
ATP + cob(I)alamin
triphosphate + adenosylcob(III)alamin
-
reaction mechanism: assimilated cobalamin is reduced to co(II)alamin, that then binds to the enzyme-ATP complex, further reduction yields a nucleophilic four coordinated Co1+ intermediate that attacks the 5'-carbon of the cosubstrate ATP to generate adenosylcobalamin and triphosphate, spectroscopic analysis, enzyme-induced base-on/base-off conversion activating the cobalamin substrate for reduction
-
-
ir
ATP + cob(I)alamin
triphosphate + adenosylcobalamin
-
polymorphic variants 239K and 239M, biosynthesis of adenosylcobalamin
-
-
?
ATP + cob(I)alamin
triphosphate + adenosylcobalamin
-
polymorphic variants 239K and 239M, ATP is highly preferred as adenosyl donor
-
-
?
cob(I)alamin + ATP
adenosylcobalamin + triphosphate
-
-
-
-
?
cob(I)alamin + ATP
adenosylcobalamin + triphosphate
-
adenosylcobalamin is a cofactor required by the methylmalonyl-CoA mutase
-
-
?
cob(I)alamin + ATP
adenosylcobalamin + triphosphate
-
cobalamin assimilation and recycling pathway, overview, enzyme deficiency causes methylmalonic aciduria, MMA, is an autosomal recessive disease with symptoms that include ketoacidosis, lethargy, recurrent vomiting, dehydration, respiratory distress, muscular hypotonia and death due to methylmalonic acid levels that are up to 1000fold greater than normal, overview
-
-
?
cob(I)alamin + ATP
adenosylcobalamin + triphosphate
-
dissociation constant (Kd) of wild-type MMAB for hydroxomethylcobalamin is 0.051 mM and for ATP is 0.365 mM, cobalamin enhances the affinity of MMAB for ATP, while ATP does not show detectable effects on cobalamin binding
-
-
?
additional information
?
-
the enzyme catalyzes the final step in the conversion of cyanocobalamin, i.e. vitamin B12, to the essential human cofactor adenosylcobalamin, defects in the enzyme through mutations in the gene encoding the enzyme can result in the metabolic disorder known as methylmalonic aciduria, MMA
-
-
?
additional information
?
-
-
the enzyme catalyzes the final step in the conversion of cyanocobalamin, i.e. vitamin B12, to the essential human cofactor adenosylcobalamin, defects in the enzyme through mutations in the gene encoding the enzyme can result in the metabolic disorder known as methylmalonic aciduria, MMA
-
-
?
additional information
?
-
only two of the three active sites within the trimer contain the bound ATP substrate, twenty residues at the enzymes N-terminus become ordered upon binding of ATP to form an ATP-binding site and an extended cleft that likely binds cobalamin, cobalamin binding site structure involving residue R186, overview
-
-
?
additional information
?
-
-
only two of the three active sites within the trimer contain the bound ATP substrate, twenty residues at the enzymes N-terminus become ordered upon binding of ATP to form an ATP-binding site and an extended cleft that likely binds cobalamin, cobalamin binding site structure involving residue R186, overview
-
-
?
additional information
?
-
no in vitro activity by mutants R215K, R225K as well as K78Q, E84K, G87R, D90N, E91K, L92S, S94L, R186W, C189Y, R190C, R191W, E193K, R194G, F212S, S217R, L220P, and L223P
-
-
?
additional information
?
-
-
no in vitro activity by mutants R215K, R225K as well as K78Q, E84K, G87R, D90N, E91K, L92S, S94L, R186W, C189Y, R190C, R191W, E193K, R194G, F212S, S217R, L220P, and L223P
-
-
?
additional information
?
-
no mediation of base-off transition of adenosylcobalamin (key step of catalytic mechanism) by mutants D64G, F83S, G87R, D90N, E91K, L92S, S94L, C189Y, R191W, E193K, R194G, F212S, S217R, L220P, and L223P
-
-
?
additional information
?
-
-
no mediation of base-off transition of adenosylcobalamin (key step of catalytic mechanism) by mutants D64G, F83S, G87R, D90N, E91K, L92S, S94L, C189Y, R191W, E193K, R194G, F212S, S217R, L220P, and L223P
-
-
?
additional information
?
-
-
the enzyme interacts with the methionine synthase reductase MSR, which catalyzes the reduction of cob(II)almin to cob(I)alamin, both enzymes activate each other, stoichiometry of the MSR-ATR system, overview
-
-
?
additional information
?
-
-
no activity with ADP and AMP
-
-
?
additional information
?
-
-
enzyme defects cause methylmalonic aciduria type B, regulation, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + cob(I)alamin
triphosphate + adenosylcob(III)alamin
-
-
adenosyltransferase enzymes lower the thermodynamic barrier of the Co2+ toCo+ reduction needed for the formation of the unique organometalic Co-C bond of adenosylcobalamin
-
?
ATP + cob(I)alamin
triphosphate + adenosylcobalamin
-
polymorphic variants 239K and 239M, biosynthesis of adenosylcobalamin
-
-
?
cob(I)alamin + ATP
adenosylcobalamin + triphosphate
additional information
?
-
cob(I)alamin + ATP
adenosylcobalamin + triphosphate
-
adenosylcobalamin is a cofactor required by the methylmalonyl-CoA mutase
-
-
?
cob(I)alamin + ATP
adenosylcobalamin + triphosphate
-
cobalamin assimilation and recycling pathway, overview, enzyme deficiency causes methylmalonic aciduria, MMA, is an autosomal recessive disease with symptoms that include ketoacidosis, lethargy, recurrent vomiting, dehydration, respiratory distress, muscular hypotonia and death due to methylmalonic acid levels that are up to 1000fold greater than normal, overview
-
-
?
additional information
?
-
the enzyme catalyzes the final step in the conversion of cyanocobalamin, i.e. vitamin B12, to the essential human cofactor adenosylcobalamin, defects in the enzyme through mutations in the gene encoding the enzyme can result in the metabolic disorder known as methylmalonic aciduria, MMA
-
-
?
additional information
?
-
-
the enzyme catalyzes the final step in the conversion of cyanocobalamin, i.e. vitamin B12, to the essential human cofactor adenosylcobalamin, defects in the enzyme through mutations in the gene encoding the enzyme can result in the metabolic disorder known as methylmalonic aciduria, MMA
-
-
?
additional information
?
-
-
the enzyme interacts with the methionine synthase reductase MSR, which catalyzes the reduction of cob(II)almin to cob(I)alamin, both enzymes activate each other, stoichiometry of the MSR-ATR system, overview
-
-
?
additional information
?
-
-
enzyme defects cause methylmalonic aciduria type B, regulation, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00158 - 0.0302
cob(I)alamin
0.00037 - 0.06
cob(I)alamin
additional information
additional information
-
0.00287
ATP
mutant D218N, in presence of 0.05 mM cob(I)alamin
0.005
ATP
mutant T161I, in presence of 0.05 mM cob(I)alamin
0.00523
ATP
mutant G97E, in presence of 0.05 mM cob(I)alamin
0.0069
ATP
native wild-type, in presence of 0.05 mM cob(I)alamin
0.00719
ATP
N-terminally octa-His tagged wild-type, in presence of 0.05 mM cob(I)alamin
0.00735
ATP
C-terminally octa-His tagged wild-type, in presence of 0.05 mM cob(I)alamin
0.00826
ATP
mutant K78R, in presence of 0.05 mM cob(I)alamin
0.00997
ATP
mutant H183Y, in presence of 0.05 mM cob(I)alamin
0.0124
ATP
mutant G63E, in presence of 0.05 mM cob(I)alamin
0.0141
ATP
mutant C119Y, in presence of 0.05 mM cob(I)alamin
0.0172
ATP
mutant S68F, in presence of 0.05 mM cob(I)alamin
0.0203
ATP
mutant G97R, in presence of 0.05 mM cob(I)alamin
0.0205
ATP
mutant D64G, in presence of 0.05 mM cob(I)alamin
0.0459
ATP
mutant R76G, in presence of 0.05 mM cob(I)alamin
0.0877
ATP
mutant S126L, in presence of 0.05 mM cob(I)alamin
0.215
ATP
mutant F83S, in presence of 0.05 mM cob(I)alamin
0.00158
cob(I)alamin
N-terminally octa-His tagged wild-type, in presence of 0.5 mM ATP
0.0016
cob(I)alamin
C-terminally octa-His tagged wild-type, in presence of 0.5 mM ATP
0.0016
cob(I)alamin
native wild-type, in presence of 0.5 mM ATP
0.00172
cob(I)alamin
mutant D218N, in presence of 0.5 mM ATP
0.00186
cob(I)alamin
mutant S68F, in presence of 0.5 mM ATP
0.00194
cob(I)alamin
mutant D64G, in presence of 0.5 mM ATP
0.00224
cob(I)alamin
mutant G63E, in presence of 0.5 mM ATP
0.00225
cob(I)alamin
mutant K78R, in presence of 0.5 mM ATP
0.00252
cob(I)alamin
mutant G97E, in presence of 0.5 mM ATP
0.00271
cob(I)alamin
mutant T161I, in presence of 0.5 mM ATP
0.00303
cob(I)alamin
mutant G97R, in presence of 0.5 mM ATP
0.00513
cob(I)alamin
mutant C119Y, in presence of 0.5 mM ATP
0.00713
cob(I)alamin
mutant H183Y, in presence of 0.5 mM ATP
0.00909
cob(I)alamin
mutant R76G, in presence of 0.5 mM ATP
0.0143
cob(I)alamin
mutant S126L, in presence of 0.5 mM ATP
0.0302
cob(I)alamin
mutant F83S, in presence of 0.5 mM ATP
0.0063
ATP
-
recombinant enzyme variant 239K
0.0068
ATP
-
pH 8.0, 37°C, recombinant wild-type GST-tagged enzyme
0.0069
ATP
-
recombinant enzyme variant 239M
0.32
ATP
-
pH 8.0, 37°C, recombinant GST-tagged mutant R191W
0.00037
cob(I)alamin
-
pH 8.0, 37°C, recombinant wild-type GST-tagged enzyme
0.0012
cob(I)alamin
-
recombinant enzyme variant 239K
0.0016
cob(I)alamin
-
recombinant enzyme variant 239M
0.06
cob(I)alamin
-
pH 8.0, 37°C, recombinant GST-tagged mutant R191W
additional information
additional information
elevated for either ATP or cobalamin or both substrates in case of mutants which show decreased adenosylcobalamin synthesis activity that can be partly corrected by increased hydroxycobalamin concentration
-
additional information
additional information
-
elevated for either ATP or cobalamin or both substrates in case of mutants which show decreased adenosylcobalamin synthesis activity that can be partly corrected by increased hydroxycobalamin concentration
-
additional information
additional information
large changes in KM for both substrates for mutants R76G, F83S and S126L
-
additional information
additional information
-
large changes in KM for both substrates for mutants R76G, F83S and S126L
-
additional information
additional information
wild-type kinetics by mutants G97E, C119Y, T161I, and H183Y
-
additional information
additional information
-
wild-type kinetics by mutants G97E, C119Y, T161I, and H183Y
-
additional information
additional information
-
-
-
additional information
additional information
-
steady-state kinetics
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
19.2 - 297.6
cob(I)alamin
0.011 - 0.037
cob(I)alamin
additional information
ATP
19.2
ATP
mutant K78R
166.2
ATP
N-terminally octa-His tagged wild-type
297.6
ATP
C-terminally octa-His tagged wild-type
19.2
cob(I)alamin
mutant K78R
29.4
cob(I)alamin
mutant G63E
31.8
cob(I)alamin
mutant D64G
34.8
cob(I)alamin
mutant S126L
43.8
cob(I)alamin
mutant D218N
46.8
cob(I)alamin
mutant S68F
48
cob(I)alamin
mutant G97R
124.2
cob(I)alamin
mutant F83S
137.4
cob(I)alamin
mutant T161I
154.8
cob(I)alamin
mutant R76G
166.2
cob(I)alamin
N-terminally octa-His tagged wild-type
169.8
cob(I)alamin
mutant G97E
169.8
cob(I)alamin
mutant H183Y
243.6
cob(I)alamin
mutant C119Y
285
cob(I)alamin
native wild-type
297.6
cob(I)alamin
C-terminally octa-His tagged wild-type
0.011
cob(I)alamin
-
pH 8.0, 37°C, recombinant GST-tagged mutant R191W
0.037
cob(I)alamin
-
pH 8.0, 37°C, recombinant wild-type GST-tagged enzyme
additional information
ATP
C-terminally octa-His tagged wild-type, kcat/KM is 0.67 per microM and min
additional information
ATP
-
C-terminally octa-His tagged wild-type, kcat/KM is 0.67 per microM and min
additional information
ATP
mutant C119Y, kcat/KM is 0.29 per microM and min
additional information
ATP
-
mutant C119Y, kcat/KM is 0.29 per microM and min
additional information
ATP
mutant D218N, kcat/KM is 0.25 per microM and min
additional information
ATP
-
mutant D218N, kcat/KM is 0.25 per microM and min
additional information
ATP
mutant D64G, kcat/KM is 0.026 per microM and min
additional information
ATP
-
mutant D64G, kcat/KM is 0.026 per microM and min
additional information
ATP
mutant F83S, kcat/KM is 0.010 per microM and min
additional information
ATP
-
mutant F83S, kcat/KM is 0.010 per microM and min
additional information
ATP
mutant G63E, kcat/KM is 0.039 per microM and min
additional information
ATP
-
mutant G63E, kcat/KM is 0.039 per microM and min
additional information
ATP
mutant G97E, kcat/KM is 0.46 per microM and min
additional information
ATP
-
mutant G97E, kcat/KM is 0.46 per microM and min
additional information
ATP
mutant G97R, kcat/KM is 0.039 per microM and min
additional information
ATP
-
mutant G97R, kcat/KM is 0.039 per microM and min
additional information
ATP
mutant H183Y, kcat/KM is 0.28 per microM and min
additional information
ATP
-
mutant H183Y, kcat/KM is 0.28 per microM and min
additional information
ATP
mutant K78R, kcat/KM is 0.039 per microM and min
additional information
ATP
-
mutant K78R, kcat/KM is 0.039 per microM and min
additional information
ATP
mutant R76G, kcat/KM is 0.056 per microM and min
additional information
ATP
-
mutant R76G, kcat/KM is 0.056 per microM and min
additional information
ATP
mutant S126L, kcat/KM is 0.007 per microM and min
additional information
ATP
-
mutant S126L, kcat/KM is 0.007 per microM and min
additional information
ATP
mutant S68F, kcat/KM is 0.045 per microM and min
additional information
ATP
-
mutant S68F, kcat/KM is 0.045 per microM and min
additional information
ATP
mutant T161I, kcat/KM is 0.46 per microM and min
additional information
ATP
-
mutant T161I, kcat/KM is 0.46 per microM and min
additional information
ATP
N-terminally octa-His tagged wild-type, kcat/KM is 0.39 per microM and min
additional information
ATP
-
N-terminally octa-His tagged wild-type, kcat/KM is 0.39 per microM and min
additional information
ATP
native wild-type, kcat/KM is 0.69 per microM and min
additional information
ATP
-
native wild-type, kcat/KM is 0.69 per microM and min
additional information
cob(I)alamin
C-terminally octa-His tagged wild-type, kcat/KM is 3.10 per microM and min
additional information
cob(I)alamin
-
C-terminally octa-His tagged wild-type, kcat/KM is 3.10 per microM and min
additional information
cob(I)alamin
mutant C119Y, kcat/KM is 0.79 per microM and min
additional information
cob(I)alamin
-
mutant C119Y, kcat/KM is 0.79 per microM and min
additional information
cob(I)alamin
mutant D218N, kcat/KM is 0.42 per microM and min
additional information
cob(I)alamin
-
mutant D218N, kcat/KM is 0.42 per microM and min
additional information
cob(I)alamin
mutant D64G, kcat/KM is 0.27 per microM and min
additional information
cob(I)alamin
-
mutant D64G, kcat/KM is 0.27 per microM and min
additional information
cob(I)alamin
mutant F83S, kcat/KM is 0.07 per microM and min
additional information
cob(I)alamin
-
mutant F83S, kcat/KM is 0.07 per microM and min
additional information
cob(I)alamin
mutant G63E, kcat/KM is 0.22 per microM and min
additional information
cob(I)alamin
-
mutant G63E, kcat/KM is 0.22 per microM and min
additional information
cob(I)alamin
mutant G97E, kcat/KM is 0.94 per microM and min
additional information
cob(I)alamin
-
mutant G97E, kcat/KM is 0.94 per microM and min
additional information
cob(I)alamin
mutant G97R, kcat/KM is 0.26 per microM and min
additional information
cob(I)alamin
-
mutant G97R, kcat/KM is 0.26 per microM and min
additional information
cob(I)alamin
mutant H183Y, kcat/KM is 0.40 per microM and min
additional information
cob(I)alamin
-
mutant H183Y, kcat/KM is 0.40 per microM and min
additional information
cob(I)alamin
mutant K78R, kcat/KM is 0.14 per microM and min
additional information
cob(I)alamin
-
mutant K78R, kcat/KM is 0.14 per microM and min
additional information
cob(I)alamin
mutant R76G, kcat/KM is 0.28 per microM and min
additional information
cob(I)alamin
-
mutant R76G, kcat/KM is 0.28 per microM and min
additional information
cob(I)alamin
mutant S126L, kcat/KM is 0.04 per microM and min
additional information
cob(I)alamin
-
mutant S126L, kcat/KM is 0.04 per microM and min
additional information
cob(I)alamin
mutant S68F, kcat/KM is 0.42 per microM and min
additional information
cob(I)alamin
-
mutant S68F, kcat/KM is 0.42 per microM and min
additional information
cob(I)alamin
mutant T161I, kcat/KM is 0.85 per microM and min
additional information
cob(I)alamin
-
mutant T161I, kcat/KM is 0.85 per microM and min
additional information
cob(I)alamin
N-terminally octa-His tagged wild-type, kcat/KM is 1.75 per microM and min
additional information
cob(I)alamin
-
N-terminally octa-His tagged wild-type, kcat/KM is 1.75 per microM and min
additional information
cob(I)alamin
native wild-type, kcat/KM is 2.97 per microM and min
additional information
cob(I)alamin
-
native wild-type, kcat/KM is 2.97 per microM and min
additional information
additional information
kcat of N-terminal octa-His tagged enzyme is 58% of native or C-terminal tagged enzyme possibly due to interference of N-terminal tag with base-off transition of adenosylcobalamin by the enzyme
-
additional information
additional information
-
kcat of N-terminal octa-His tagged enzyme is 58% of native or C-terminal tagged enzyme possibly due to interference of N-terminal tag with base-off transition of adenosylcobalamin by the enzyme
-
additional information
additional information
mutations in conserved regions E84-S94 and R186-R194 lead to abolished enzymatic activity and support their implication in the enzymes active site
-
additional information
additional information
-
mutations in conserved regions E84-S94 and R186-R194 lead to abolished enzymatic activity and support their implication in the enzymes active site
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.026
-
reductant: PduS protein, specific activity of hATR using different electron sources for the adenosylation of cob(II)alamin
0.027
-
purified recombinant GST-tagged mutant R191W
0.072
-
reductant: NADPH-dependent ferredoxin protein reductase, specific activity of hATR using different electron sources for the adenosylation of cob(II)alamin
0.089
-
purified recombinant GST-tagged wild-type enzyme
0.19
-
recombinant enzyme variant 239M
0.22
-
recombinant enzyme variant 239K
0.25
-
reductant: dihydroflavin, specific activity of hATR using different electron sources for the adenosylation of cob(II)alamin
0.49
-
reductant: Ti(III)citrate, specific activity of hATR using different electron sources for the adenosylation of cob(II)alamin
0.061
pH 8.0, 37°C
0.061
human ATR containing mitochondrial targeting sequence, expressed in E. coli and forming inclusion bodies
0.098
pH 8.0, 37°C
0.098
human ATR with no mitochondrial targeting sequence, expressed in E. coli and forming inclusion bodies
additional information
substantially reduced Vmax for mutants G63E, D64G, S68F, K78R, G97R and D218N
additional information
-
substantially reduced Vmax for mutants G63E, D64G, S68F, K78R, G97R and D218N
additional information
wild-type kinetics by mutants G97E, C119Y, T161I, and H183Y
additional information
-
wild-type kinetics by mutants G97E, C119Y, T161I, and H183Y
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
C119Y
wild-type kinetics, decreased adenosylcobalamin production in vivo, impaired protein folding leads to degradation and, thus, low expression, no rescue of ATR-deficient Salmonella strain BE620
C189Y
inactive in vitro (10fold excess of substrate compared to standard), decreased adenosylcobalamin production in vivo, impaired protein folding leads to degradation and, thus, low expression (but can be purified), no rescue of ATR-deficient Salmonella strain BE620
D218N
substantially reduced Vmax, decreased adenosylcobalamin production in vivo partly corrected by increased hydroxycobalamin concentration, part of proposed active site role in ATP/cobalamin binding, no rescue of ATR-deficient Salmonella strain BE620
D64G
substantially reduced Vmax, decreased adenosylcobalamin production in vivo partly corrected by increased hydroxycobalamin concentration, part of proposed active site, role in ATP/cobalamin binding, no rescue of ATR-deficient Salmonella strain BE620
D90N
inactive in vitro (10fold excess of substrate compared to standard)
E193K
inactive in vitro (10fold excess of substrate compared to standard), conserved residue, mutation found in methylmalonic aciduria patients
E84K
inactive in vitro (10fold excess of substrate compared to standard)
E91K
inactive in vitro (10fold excess of substrate compared to standard)
F212S
inactive in vitro (10fold excess of substrate compared to standard)
F83S
large change in KM for ATP and cob(I)alamin, F83 has direct contact with ATP
G63E
substantially reduced Vmax, decreased adenosylcobalamin production in vivo partly corrected by increased hydroxycobalamin concentration, role in ATP/cobalamin binding, no rescue of ATR-deficient Salmonella strain BE620
G87R
inactive in vitro (10fold excess of substrate compared to standard)
G97E
wild-type kinetics, mutation distant from proposed active site, no rescue of ATR-deficient Salmonella strain BE620 possibly due to impaired reduction of cob(II)alamin to cob(I)alamin, expressed at wild-type levels
G97R
substantially reduced Vmax, mutation distant from proposed active site, no rescue of ATR-deficient Salmonella strain BE620
H183Y
wild-type kinetics, mutation distant from proposed active site, no rescue of ATR-deficient Salmonella strain BE620 possibly due to impaired reduction of cob(II)alamin to cob(I)alamin, expressed at wild-type levels
K78Q
inactive in vitro (10fold excess of substrate compared to standard)
K78R
substantially reduced Vmax, decreased adenosylcobalamin production in vivo partly corrected by increased hydroxycobalamin concentration, role in ATP/cobalamin binding, no rescue of ATR-deficient Salmonella strain BE620
L220P
inactive in vitro (10fold excess of substrate compared to standard)
L223P
inactive in vitro (10fold excess of substrate compared to standard)
L92S
inactive in vitro (10fold excess of substrate compared to standard)
R186W
inactive in vitro (10fold excess of substrate compared to standard), decreased adenosylcobalamin production in vivo, impaired protein folding leads to degradation and, thus, low expression (but can be purified), no rescue of ATR-deficient Salmonella strain BE620, conserved residue, mutation found in methylmalonic aciduria patients
R190C
inactive in vitro (10fold excess of substrate compared to standard), decreased adenosylcobalamin production in vivo, impaired protein folding leads to degradation and, thus, low expression (but can be purified), no rescue of ATR-deficient Salmonella strain BE620, conserved residue, mutation found in methylmalonic aciduria patients
R191W
inactive in vitro (10fold excess of substrate compared to standard), decreased adenosylcobalamin production in vivo, impaired protein folding leads to degradation and, thus, low expression (but can be purified), no rescue of ATR-deficient Salmonella strain BE620, conserved residue, mutation found in methylmalonic aciduria patients
R194G
inactive in vitro (10fold excess of substrate compared to standard)
R215K
inactive in vitro (10fold excess of substrate compared to standard), lack of activity in vitro, decreased adenosylcobalamin production in vivo partly corrected by increased hydroxycobalamin concentration, part of proposed active site, role in ATP/cobalamin binding, no rescue of ATR-deficient Salmonella strain BE620
R225K
lack of activity in vitro, decreased adenosylcobalamin production in vivo partly corrected by increased hydroxycobalamin concentration, part of proposed active site, role in ATP/cobalamin binding, no rescue of ATR-deficient Salmonella strain BE620
R76G
large change in KM for ATP and cob(I)alamin, decreased adenosylcobalamin production in vivo partly corrected by increased hydroxycobalamin concentration, part of proposed active site, role in ATP/cobalamin binding, no rescue of ATR-deficient Salmonella strain BE620
S126L
large change in KM for ATP and cob(I)alamin, decreased adenosylcobalamin production in vivo partly corrected by increased hydroxycobalamin concentration, part of proposed active site, role in ATP/cobalamin binding, no rescue of ATR-deficient Salmonella strain BE620
S217R
inactive in vitro (10fold excess of substrate compared to standard)
S68F
substantially reduced Vmax, residue S68 has role in ATP-binding
S94L
inactive in vitro (10fold excess of substrate compared to standard)
T161I
wild-type kinetics, decreased adenosylcobalamin production in vivo but rescues ATR-deficient Salmonella strain BE620 possibly due to impaired reduction of cob(II)alamin to cob(I)alamin, expressed at wild-type levels
E193K
-
site-directed mutagenesis, the mutant enzyme is not expressed
R186W
-
catalytically inactive patient mutation leading to the inherited disorder methylmalonic aciduria. Mutant is examined using intrinsic fluorescence quenching of MMAB as a measure of ligand-binding. R190H and R186W significantly disrupt the affinity between MMAB and adenosylcobalmin. Arg 186 and Arg-190 may be critical for the transfer of the 5'-deoxyadenosyl group from ATP to cob(I)alamin, possibly by contributing to the precise positioning of the two substrates to permit catalysis to occur
R190H
-
catalytically inactive patient mutation leading to the inherited disorder methylmalonic aciduria. Mutant is examined using intrinsic fluorescence quenching of MMAB as a measure of ligand-binding. R190H and R186W significantly disrupt the affinity between MMAB and adenosylcobalmin. Arg 186 and Arg-190 may be critical for the transfer of the 5'-deoxyadenosyl group from ATP to cob(I)alamin, possibly by contributing to the precise positioning of the two substrates to permit catalysis to occur
R191W/A135T
-
site-directed mutagenesis, the mutant enzyme shows 30% reduced activity compared to the wild-type enzyme
additional information
enzyme mutations at residues Gly97, Ser174, Arg186, Arg190, Arg191, Glu193, and Gln234 can result in the metabolic disorder known as methylmalonic aciduria, MMA, overview
additional information
-
enzyme mutations at residues Gly97, Ser174, Arg186, Arg190, Arg191, Glu193, and Gln234 can result in the metabolic disorder known as methylmalonic aciduria, MMA, overview
additional information
-
construction of transgenic C57/Bl6 mice by expression of the human enzyme using an adeno-associated virus vector with primer pairs specific to the cytomegalovirus enhancer/chicken beta-actin, CBAT, promoter, quantitative and semiquantitative expression analysis in murine liver, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Leal, N.A.; Park, S.D.; Kima, P.E.; Bobik, T.A.
Identification of the human and bovine ATP:Cob(I)alamin adenosyltransferase cDNAs based on complementation of a bacterial mutant
J. Biol. Chem.
278
9227-9234
2003
Bos taurus, Homo sapiens (Q96EY8), Homo sapiens
brenda
Stich, T.A.; Yamanishi, M.; Banerjee, R.; Brunold, T.C.
Spectroscopic evidence for the formation of a four-coordinate Co2+ cobalamin species upon binding to the human ATP:cobalamin adenosyltransferase
J. Am. Chem. Soc.
127
7660-7661
2005
Homo sapiens
brenda
Leal, N.A.; Olteanu, H.; Banerjee, R.; Bobik, T.A.
Human ATP:cob(I)alamin adenosyltransferase and its interaction with methionine synthase reductase
J. Biol. Chem.
279
47536-47542
2004
Homo sapiens
brenda
Schubert, H.L.; Hill, C.P.
Structure of ATP-bound human ATP:cobalamin adenosyltransferase
Biochemistry
45
15188-15196
2006
Homo sapiens (Q96EY8), Homo sapiens
brenda
Erger, K.E.; Conlon, T.J.; Leal, N.A.; Zori, R.; Bobik, T.A.; Flotte, T.R.
In vivo expression of human ATP:cob(I)alamin adenosyltransferase (ATR) using recombinant adeno-associated virus (rAAV) serotypes 2 and 8
J. Gene Med.
9
462-469
2007
Homo sapiens
brenda
Zhang, J.; Dobson, C.M.; Wu, X.; Lerner-Ellis, J.; Rosenblatt, D.S.; Gravel, R.A.
Impact of cblB mutations on the function of ATP:cob(I)alamin adenosyltransferase in disorders of vitamin B12 metabolism
Mol. Genet. Metab.
87
315-322
2006
Homo sapiens
brenda
Fan, C.; Bobik, T.A.
Functional characterization and mutation analysis of human ATP:Cob(I)alamin adenosyltransferase
Biochemistry
47
2806-2813
2008
Homo sapiens (Q96EY8), Homo sapiens
brenda
Mera, P.; Escalante-Semerena, J.
Dihydroflavin-driven adenosylation of 4-coordinate Co(II) corrinoids: are cobalamin reductases enzymes or electron transfer proteins?
J. Biol. Chem.
285
2911-2917
2010
Homo sapiens, Limosilactobacillus reuteri
brenda
Zhang, J.; Wu, X.; Padovani, D.; Schubert, H.; Gravel, R.
Ligand-binding by catalytically inactive mutants of the cblB complementation group defective in human ATP:cob(I)alamin adenosyltransferase
Mol. Genet. Metab.
98
278-284
2009
Homo sapiens
brenda